Bryan E. Linggi, Ph.D. - Publications

Affiliations: 
2003 Vanderbilt University, Nashville, TN 
Area:
Biochemistry, Molecular Biology

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Taylor RC, Webb Robertson BJ, Markillie LM, Serres MH, Linggi BE, Aldrich JT, Hill EA, Romine MF, Lipton MS, Wiley HS. Changes in translational efficiency is a dominant regulatory mechanism in the environmental response of bacteria. Integrative Biology : Quantitative Biosciences From Nano to Macro. 5: 1393-406. PMID 24081429 DOI: 10.1039/C3Ib40120K  0.349
2006 Linggi B, Carpenter G. ErbB-4 s80 intracellular domain abrogates ETO2-dependent transcriptional repression. The Journal of Biological Chemistry. 281: 25373-80. PMID 16815842 DOI: 10.1074/Jbc.M603998200  0.424
2005 Linggi BE, Brandt SJ, Sun ZW, Hiebert SW. Translating the histone code into leukemia. Journal of Cellular Biochemistry. 96: 938-50. PMID 16167339 DOI: 10.1002/Jcb.20604  0.634
2003 Steffen B, Serve H, Berdel WE, Agrawal S, Linggi B, Büchner T, Hiebert SW, Müller-Tidow C. Specific protein redirection as a transcriptional therapy approach for t(8;21) leukemia. Proceedings of the National Academy of Sciences of the United States of America. 100: 8448-53. PMID 12819347 DOI: 10.1073/Pnas.1330293100  0.739
2003 Hiebert SW, Reed-Inderbitzin EF, Amann J, Irvin B, Durst K, Linggi B. The t(8;21) fusion protein contacts co-repressors and histone deacetylases to repress the transcription of the p14ARF tumor suppressor. Blood Cells, Molecules & Diseases. 30: 177-83. PMID 12732181 DOI: 10.1016/S1079-9796(03)00021-4  0.634
2002 Linggi B, Müller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, Berdel WE, van der Reijden B, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP, Hiebert SW. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Nature Medicine. 8: 743-50. PMID 12091906 DOI: 10.1038/Nm726  0.747
2001 Hiebert SW, Lutterbach B, Durst K, Wang L, Linggi B, Wu S, Wood L, Amann J, King D, Hou Y. Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins Cancer Chemotherapy and Pharmacology. 48. PMID 11587363 DOI: 10.1007/S002800100302  0.635
2000 Lutterbach B, Westendorf JJ, Linggi B, Isaac S, Seto E, Hiebert SW. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia Journal of Biological Chemistry. 275: 651-656. PMID 10617663 DOI: 10.1074/Jbc.275.1.651  0.736
1998 Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Molecular and Cellular Biology. 18: 7176-84. PMID 9819404 DOI: 10.1128/Mcb.18.12.7176  0.746
Show low-probability matches.